Id |
Subject |
Object |
Predicate |
Lexical cue |
T24 |
0-40 |
Sentence |
denotes |
Figure 1 T-cell polarisation in COVID-19 |
T25 |
41-214 |
Sentence |
denotes |
IL-33 released from virus-damaged cells might induce dysregulated GATA3+Foxp3+ Tregs and promote IL-2 production by dendritic cells, resulting in further expansion of Tregs. |
T26 |
215-350 |
Sentence |
denotes |
IL-33 might also elicit differentiation of ILC2, with TGFβ enhancing ST2 expression on these cells and facilitating production of IL-9. |
T27 |
351-523 |
Sentence |
denotes |
IL-9 in turn stimulates expansion of effector memory Vγ9Vδ2+ T cells with mixed Th1 and Th17 profiles that express CXCR3 and are recruited to the lungs by CXCL9 and CXCL10. |
T28 |
524-707 |
Sentence |
denotes |
IL-9 possibly induces its own transcription factor PU.1 and thus act in an autocrine and paracrine manner (along with TGFβ) to drive proliferation and survival of ILC2 and γδ T cells. |
T29 |
708-817 |
Sentence |
denotes |
Additional positive loops might be fed by IFNγ, which triggers production of CXCL9 and CXCL10 by macrophages. |
T30 |
818-1037 |
Sentence |
denotes |
In severe forms of COVID-19, IL-33, along with IL-2 and IL-7 released by dendritic cells, might further stimulate T-cell expansion through STAT5 and induce production of large amounts of GM-CSF by γδ and T helper cells. |
T31 |
1038-1275 |
Sentence |
denotes |
At advanced stages of disease, aberrant activation of the MyD88-related NF-κB pathway and activation of the NLRP3 inflammasome might induce virus-exposed cells and infiltrating monocytes–macrophages to overproduce IL-1β, IL-23, and IL-6. |
T32 |
1276-1478 |
Sentence |
denotes |
IL-1β, IL-23, IL-6, and IL-7 act on STAT3 and RORC, thus promoting differentiation of CCR2+ T cells that are recruited to the lungs by CCL2 and CCL8 into γδT17 and Th17 cells producing IL-17 and GM-CSF. |
T33 |
1479-1568 |
Sentence |
denotes |
In turn, GM-CSF might further recruit and activate proinflammatory monocytes–macrophages. |
T34 |
1569-1602 |
Sentence |
denotes |
CCR=C-C motif chemokine receptor. |
T35 |
1603-1634 |
Sentence |
denotes |
CCL=C-C motif chemokine ligand. |
T36 |
1635-1669 |
Sentence |
denotes |
CXCL=C-X-C motif chemokine ligand. |
T37 |
1670-1700 |
Sentence |
denotes |
CXCR=C-X-C chemokine receptor. |
T38 |
1701-1727 |
Sentence |
denotes |
Foxp=forkhead box protein. |
T39 |
1728-1753 |
Sentence |
denotes |
GATA=GATA-binding factor. |
T40 |
1754-1810 |
Sentence |
denotes |
GM-CSF=granulocyte-macrophage colony-stimulating factor. |
T41 |
1811-1826 |
Sentence |
denotes |
IL=interleukin. |
T42 |
1827-1860 |
Sentence |
denotes |
ILC2=type 2 innate lymphoid cell. |
T43 |
1861-1916 |
Sentence |
denotes |
MyD88=myeloid differentiation primary response protein. |
T44 |
1917-1946 |
Sentence |
denotes |
NF-κB=nuclear factor-kappa B. |
T45 |
1947-1999 |
Sentence |
denotes |
NLRP=NACHT, LRR, and PYD domains-containing protein. |
T46 |
2000-2031 |
Sentence |
denotes |
PU.1=transcription factor PU.1. |
T47 |
2032-2064 |
Sentence |
denotes |
RORC=nuclear receptor ROR-gamma. |
T48 |
2065-2082 |
Sentence |
denotes |
ST2=ST2 receptor. |
T49 |
2083-2134 |
Sentence |
denotes |
STAT=signal transducer and transcription activator. |
T50 |
2135-2166 |
Sentence |
denotes |
TGF=transforming growth factor. |
T51 |
2167-2179 |
Sentence |
denotes |
Th=T-helper. |
T52 |
2180-2204 |
Sentence |
denotes |
TLR=toll-like receptors. |
T53 |
2205-2228 |
Sentence |
denotes |
Treg=regulatory T cell. |